Axon Enterprise reported a headline-grabbing quarter: Q2 FY2026 revenue of $904.4 million, up 35% year-over-year, and EPS of $1.88, beating estimates by $0.04. The company raised its full-year guidance to 30%-32% growth. But the market’s reaction was brutal—the stock plunged 14.3% in after-hours trading, wiping out $87 per share. That disconnect between the press release and the price action is the real story.
1. The Lede & The Real Story
Investors aren’t buying the narrative of ‘record growth’ and ‘AI-driven momentum.’ They’re seeing a company whose GAAP net income fell to just $29 million on $904 million in revenue—a net margin of 3.2%, down from 6.8% in Q1 FY2026 (net income of $55 million on $807 million). The revenue growth is real, but the profitability is deteriorating, and the market is punishing the stock for it. The CEO’s opening boast about his Cybertruck and OpenAI’s math breakthroughs feels like a distraction from the fact that Axon is spending heavily on AI and drones while its core TASER business faces saturation and legal scrutiny. The real story is that Axon is a growth story with a profitability problem, and the market has finally noticed.
Subscribe to continue reading
Subscribe to get access to the rest of this post and other subscriber-only content.